Table: Cosmos Pharmaceutical -2016/17 group results

Cosmos Pharmaceutical

10/07/2017 07:00

Jul 10 (Reuters)-  
          Cosmos Pharmaceutical Corp.  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              May 31, 2017    May 31, 2016   May 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales          502.73          447.27         550.00        270.40    
               (+12.4 pct)     (+9.5 pct)     (+9.4 pct)    (+9.5 pct)  
  Operating       22.24           18.65          22.30         11.20    
               (+19.2 pct)     (+9.2 pct)     (+0.3 pct)    (-5.7 pct)  
  Recurring       24.59           20.69          24.60         12.35    
               (+18.8 pct)     (+8.7 pct)     (+0.0 pct)    (-5.3 pct)  
  Net 
  Net             18.22           12.44          17.00          8.53    
               (+46.5 pct)     (+6.3 pct)     (-6.7 pct)    (-1.8 pct)  
  EPS          919.99 yen      628.05 yen     858.60 yen    430.82 yen  
  Ann Div       80.00 yen       65.00 yen      90.00 yen                
  -Q2 Div       35.00 yen       30.00 yen      45.00 yen                
  -Q4 Div       45.00 yen       35.00 yen      45.00 yen                
   
  NOTE - Cosmos Pharmaceutical Corp.. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T 
  ((Tokyo Headline News Desk +813 6441 1812))